Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer

Androgen deprivation therapy (ADT) remains a key approach in the treatment of prostate cancer (PCa). However, PCa inevitably relapses and becomes ADT resistant. Besides androgens, there is evidence that thyroid hormone thyroxine (T4) and its active form 3,5,3′‐triiodo‐l‐thyronine (T3) are involved i...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksoy, Osman, Pencik, Jan, Hartenbach, Markus, Moazzami, Ali A., Schlederer, Michaela, Balber, Theresa, Varady, Adam, Philippe, Cecile, Baltzer, Pascal A., Mazumder, Bismoy, Whitchurch, Jonathan B., Roberts, Christopher J., Haitel, Andrea, Herac, Merima, Susani, Martin, Mitterhauser, Markus, Marculescu, Rodrig, Stangl‐Kremser, Judith, Hassler, Melanie R., Kramer, Gero, Shariat, Shahrokh F., Turner, Suzanne D., Tichy, Boris, Oppelt, Jan, Pospisilova, Sarka, Hartenbach, Sabrina, Tangermann, Simone, Egger, Gerda, Neubauer, Heidi A., Moriggl, Richard, Culig, Zoran, Greiner, Georg, Hoermann, Gregor, Hacker, Marcus, Heery, David M., Merkel, Olaf, Kenner, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Molecular Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756625/
https://www.ncbi.nlm.nih.gov/pubmed/33034050
http://dx.doi.org/10.1002/ijc.33332

Ejemplares similares

Ejemplares similares